P. Damsbo

1.8k citations

20 papers · 1.4k indexed · h-index 18

Impact in

Endocrinology, Diabetes and Metabolism top 2%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
Nephrology top 5%

Papers in

Endocrinology, Diabetes and Metabolism 9
- Diabetes Management and Research 7
- Diabetes Treatment and Management 6
Transplantation 1

Co-authors: Henning Beck‐Nielsen Allan Vaag Ole Hother‐Nielsen Birgitte Hylleberg J. B. Larsen Kevin K. Ng Aase Handberg K. Bech
Journals: Diabetes Care (6 papers)Diabetologia (4 papers)Diabetic Medicine (2 papers)American Journal of Physiology-Endocrinology and Metabolism (1 paper)Clinical & Experimental Immunology (1 paper)
Partner nations: Denmark United States Australia

In The Last Decade

P. Damsbo

20 papers receiving 1.3k citations

Peers

Countries citing papers authored by P. Damsbo

Since Specialization

Citations

This map shows the geographic impact of P. Damsbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Damsbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Damsbo more than expected).

Fields of papers citing papers by P. Damsbo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Damsbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Damsbo. The network helps show where P. Damsbo may publish in the future.

Co-authors

The 25 scholars most cited alongside P. Damsbo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. Damsbo Line = papers co-authored together P. Damsbo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A randomized, double‐blind, placebo‐controlled, dose‐escalation first‐in‐man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX001, in patients with mild to moderate plaque psoriasis Journal of the European Academy of Dermatology and Venereology ·Silje Haukali Omland, Antje Habicht, P. Damsbo, Dongxu Li, Berit Johansen, Robert Gniadecki	2017	28
2	A Feasibility Study of a 3-Day Basal-Bolus Insulin Delivery Device in Individuals With Type 2 Diabetes Diabetes Care ·Julia K. Mader, Leslie C. Lilly, Felix Aberer, Stefan Korsatko, Ellie S. Strock, Roger S. Mazze, P. Damsbo, Thomas R. Pieber	2014	10
3	Repaglinide treatment amplifies first‐phase insulin secretion and high‐frequency pulsatile insulin release in Type 2 diabetes Diabetic Medicine ·Malene Hollingdal, Jeppe Sturis, M.‐A. Gall, P. Damsbo, Steven M. Pincus, Johannes D. Veldhuis, Shirou Uchiyama, Ole Schmitz, Claus Bogh Juhl	2005	18
4	Glucagon-Like Peptide-1 Infusion Must Be Maintained for 24 h/day to Obtain Acceptable Glycemia in Type 2 Diabetic Patients Who Are Poorly Controlled on Sulphonylurea Treatment Diabetes Care ·J. B. Larsen, Birgitte Hylleberg, Kevin K. Ng, P. Damsbo	2001	148
5	Pharmacology and clinical experience with repaglinide Expert Opinion on Investigational Drugs ·Massimo Massi‐Benedetti, P. Damsbo	2000	22
6	A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients. Diabetes Care ·P. Damsbo, Per Clauson, Thomas Marbury, Kristian Windfeld	1999	76
7	Flexible prandial glucose regulation with repaglinide in patients with Type 2 diabetes Diabetes Research and Clinical Practice ·P. Damsbo, Thomas Marbury, Vibeke Hatorp, Per Clauson, B.F. Wang	1999	29
8	Irreversibility of the Defect in Glycogen Synthase Activity in Skeletal Muscle From Obese Patients With NIDDM Treated With Diet and Metformin Diabetes Care ·P. Damsbo, C. Balakrishnan, Allan Vaag, Ole Hother‐Nielsen, Henning Beck‐Nielsen	1998	22
9	A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes. Diabetes Care ·Ronald Goldberg, Daniel Einhorn, Charles Lucas, Marc Rendell, P. Damsbo, Sandrine Pages, Poul Strange, Robert G. Brodows	1998	99
10	β‐Cell function and glucose and lipid oxidation in Graves’ disease Clinical Endocrinology ·K. Bech, P. Damsbo, Ebbe Eldrup, Henning Beck‐Nielsen, Zenzyûrô KURODA, S. G. Hartling, Sally R. Ke, Sten Madsbad	1996	45
11	Circulating monocytes are activated in newly diagnosed type 1 diabetes mellitus patients Clinical & Experimental Immunology ·Knud Josefsen, Henrik Nielsen, Steinar Lorentzen, P. Damsbo, Karsten Buschard	1994	27
12	Pancreatic beta-cell function and glucose metabolism in human segmental pancreas and kidney transplantation American Journal of Physiology-Endocrinology and Metabolism ·Erik Christiansen, Henning Boje Andersen, K Rasmussen, Niels Juel Christensen, Klaus Ølgaard, Preben Olund Kirkegaard, B. Tronier, Aage Vølund, P. Damsbo, F Burcharth, al. et	1993	26
13	Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with Type 2 (non-insulin-dependent) diabetes mellitus Diabetologia ·Allan Vaag, P. Damsbo, Ole Hother‐Nielsen, Henning Beck‐Nielsen	1992	58
14	Insulin Resistance in Skeletal Muscles in Patients With NIDDM Diabetes Care ·Henning Beck‐Nielsen, Allan Vaag, P. Damsbo, Aase Handberg, Ole Hother‐Nielsen, Jan Erik Henriksen, Peter Thye‐Rønn	1992	66
15	Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors. The Journal of Clinical Endocrinology & Metabolism ·Barbara B. Kahn, Andrei S. Rosen, J. F. Bak, P. H. Andersen, P. Damsbo, Sten Lund, Oluf Pedersen	1992	45
16	Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation ·Allan Vaag, P. Skøtt, P. Damsbo, M.-A. Gall, Erik A. Richter, Henning Beck‐Nielsen	1991	108
17	Reduced glycogen synthase activity in skeletal muscle from obese patients with and without Type 2 (non-insulin-dependent) diabetes mellitus Diabetologia ·P. Damsbo, Allan Vaag, Ole Hother‐Nielsen, Henning Beck‐Nielsen	1991	169
18	Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients Diabetologia ·M.‐A. Gall, Peter Rossing, D. Albrice, P. Damsbo, Allan Vaag, K. Bech, A. Dejgaard, M. Lauritzen, E Lauritzen, Philip Hougaard, Henning Beck‐Nielsen, H.‐H. Parving	1991	285
19	Expression of insulin regulatable glucose transporters in skeletal muscle from Type 2 (non-insulin-dependent) diabetic patients Diabetologia ·Aase Handberg, Allan Vaag, P. Damsbo, Henning Beck‐Nielsen, J. Vinten	1990	133
20	Activated CD4+ and CD8+ T‐lymphocytes in Newly Diagnosed Type 1 Diabetes: a Prospective Study Diabetic Medicine ·Karsten Buschard, P. Damsbo, C. Röpke	1990	11

About P. Damsbo

P. Damsbo is a scholar working on Endocrinology, Diabetes and Metabolism, Transplantation, Physiology, Cell Biology and Pharmacology, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (8 papers), Diabetes Management and Research (7 papers), Diabetes Treatment and Management (6 papers), Diet and metabolism studies (6 papers), Adipose Tissue and Metabolism (5 papers), Diabetes and associated disorders (4 papers), Muscle metabolism and nutrition (4 papers) and Pharmacology and Obesity Treatment (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (722 citations), Nephrology (139 citations), Physiology (423 citations), Cell Biology (187 citations) and Pharmacology (155 citations). P. Damsbo has collaborated with scholars based in Denmark, United States and Australia. Frequent co-authors include Henning Beck‐Nielsen, Allan Vaag, Ole Hother‐Nielsen, Birgitte Hylleberg, J. B. Larsen, Kevin K. Ng, Aase Handberg, K. Bech, J. Vinten and M.‐A. Gall. Their work appears in journals such as Diabetes Care, Diabetologia, Diabetic Medicine, American Journal of Physiology-Endocrinology and Metabolism and Clinical & Experimental Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact